510(k) Report

510(k) · Cleared

Cleared

Clever Check TD-3250 Blood Glucose and Blood Pressure Measurement System, Model TD-3250

K061073510(k) TraditionalCleared Jun 2, 200646-day reviewClass II21 CFR 870.1130

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Taidoc Technology Corporation · DXN System, Measurement, Blood-Pressure, Non-Invasive

Cleared on Jun 2, 2006 as substantially equivalent to K042005 (Taidoc Technology Corporation, 2004) and 1 other predicate after a 46-day review. Its family tree reaches back 1 generation to 2001. 3 later devices descend from it.

Decided
Jun 2, 2006
Review
46 days
Class
Class II
Product code
DXN
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K012636 (2001). 2 ancestors in all. 3 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2004: 1 other ancestor2007: 1 descendant cleared2010: 1 descendant cleared2008: 1 descendant clearedK012636 · Bptru Automated Non-Invasive Blood Pressure Monitor, Model BPM-100 · Vsm Technology, Inc. · 2001200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant2 generations forward: 2 descendants K012636 · Bptru Automated Non-Invasive Blood Pressure Monitor, Model BPM-100 · Vsm Technology, Inc. · 20010
  1. Root · 1 generation backK012636 Bptru Automated Non-Invasive Blood Pressure Monitor, Model BPM-100Vsm Technology, Inc. · 2001
  2. This deviceK061073 Clever Check TD-3250 Blood Glucose and Blood Pressure Measurement…Taidoc Technology Corporation · 2006
  3. Descendant · cites it directly · 2 of its ownK062800 Clever Chek TD-3213/ Clever Chek TD-3215/ DR. T TD-3216/ Clever Chek…Taidoc Technology Corporation · 2007
  4. Descendant · 2 generations on · 0 of its ownK092875 Echo TD-3227 Dual Blood Pressure/Blood Glucose MeterTaidoc Technology Corporation · 2010
  5. Descendant · 2 generations on · 0 of its ownK080014 Clever Chek TD-3250C Blood Glucose Plus Blood Pressure Monitoring…Taidoc Technology Corporation · 2008

Most influential descendants

Showing 3 of 3 · See all
  • K062800Clever Chek TD-3213/ Clever Chek TD-3215/ DR. T TD-3216/ Clever Chek TD-3217/ Clever…Taidoc Technology Corporation · 2007 · cites it directly2descendants
  • K092875Echo TD-3227 Dual Blood Pressure/Blood Glucose MeterTaidoc Technology Corporation · 2010 · 2 generations on0descendants
  • K080014Clever Chek TD-3250C Blood Glucose Plus Blood Pressure Monitoring SystemTaidoc Technology Corporation · 2008 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K012636Bptru Automated Non-Invasive Blood Pressure Monitor, Model BPM-100Vsm Technology, Inc.2001—
0 (this device)K061073Clever Check TD-3250 Blood Glucose and Blood Pressure Measurement System…Taidoc Technology Corporation2006—
+1K062800Clever Chek TD-3213/ Clever Chek TD-3215/ DR. T TD-3216/ Clever Chek TD-3217/…Taidoc Technology Corporation2007—
+2K092875Echo TD-3227 Dual Blood Pressure/Blood Glucose MeterTaidoc Technology Corporation2010—
+2K080014Clever Chek TD-3250C Blood Glucose Plus Blood Pressure Monitoring SystemTaidoc Technology Corporation2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
200810
201010
FIG. 1 — Lineage of K061073, 2001–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DXN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXN device

  1. #1 K222125 Arm Blood Pressure Monitor, models AOJ-30A…score 18.5 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K042005Achtung TD-4207, Clever Chek TD-4209, Clever Chek TD-4222
Summary page 1
…Blood Glucose Test Strips Manufacturer TaiDoc Technology Corporation. VSM Med[Tech Ltd. 5 10 (k) Number K042005; K0 12636 iii…
Taidoc Technology Corporation2004—
*K012636Bptru Automated Non-Invasive Blood Pressure Monitor, Model BPM-100
Summary page 1
…lood Glucose Test Strips Manufacturer TaiDoc Technology Corporation. VSM Med[Tech Ltd. 5 10 (k) Number K042005; K0 12636 iii Pa…
Vsm Technology, Inc.2001—

Also cleared against K042005: 2 other devices →

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K062800Clever Chek TD-3213/ Clever Chek TD-3215/ DR. T TD-3216/ Clever Chek TD-3217/ Clever…Taidoc Technology Corporation20072

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • Of its descendants, K062800 (Taidoc Technology Corporation, 2007) has gone furthest, with 2 descendants of its own.
  • 2 other devices also cite its predicate K042005.

How does its category compare?

All DXN devices

DXN System, Measurement, Blood-Pressure, Non-Invasive: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DXN

28in 2025

2007: 272008: 232009: 462010: 432011: 342012: 362013: 342014: 292015: 302016: 302017: 332018: 222019: 332020: 242021: 232022: 252023: 352024: 172025: 282026 (partial year): 29
2007high 46 (2009) · low 17 (2024)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXN

142in 2025

2007: 118 days median2008: 82 days median2009: 73 days median2010: 94 days median2011: 72 days median2012: 116 days median2013: 150 days median2014: 133 days median2015: 97 days median2016: 144 days median2017: 184 days median2018: 235 days median2019: 156 days median2020: 198 days median2021: 190 days median2022: 137 days median2023: 182 days median2024: 107 days median2025: 142 days median2026 (partial year): 147 days median
2007high 235 (2018) · low 72 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXN

3in 2024

2008: 12009: 32011: 12013: 12016: 12019: 12024: 3
2007high 3 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DXN

239in 2025

2007: 212008: 82009: 172010: 142011: 102012: 192013: 722014: 472015: 622016: 542017: 902018: 6172019: 962020: 1302021: 1622022: 1552023: 1622024: 2702025: 239
2007high 617 (2018) · low 8 (2008)2025

MAUDE reports naming product code DXN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200727118021
2008238218
20094673317
20104394014
20113472110
201236116019
201334150172
201429133047
20153097062
201630144154
201733184090
2018222350617
201933156196
2020241980130
2021231900162
2022251370155
2023351820162
2024171073270
2025281420239
2026291470—

What is it indicated for?

The Clever Chek TD-3250 Blood Glucose and Blood Pressure Measurement System is intended for in vitro diagnostic use. The system is intended to be used for the quantitative measurement of capillary whole blood from the fingertip. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of a diabetes control program. It is not intended for the diagnosis of or screening for…

Read the full statement (139 words)

The Clever Chek TD-3250 Blood Glucose and Blood Pressure Measurement System is intended for in vitro diagnostic use. The system is intended to be used for the quantitative measurement of capillary whole blood from the fingertip. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of a diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, and is not intended for use on neonates.

The system is also intended to be used to measure non-invasively the systolic and diastolic blood pressure and pluse rate of an adult individual, over age 16, at home by using a technique in which an inflatable cuff is wrapped around the arm. The cuff circumference is limited to 9.4 inches to - 13.8 inches.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K061073: Clever Check TD-3250 Blood Glucose and Blood Pressure Measurement System, Model TD-3250.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K061073

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026